Literature DB >> 1792902

Coronary arterial calcification in Kawasaki disease.

T Nakada1, S Yonesaka, Y Sunagawa, K Tomimoto, T Takahashi, T Matsubara, H Furukawa, K Kamimura, S Naka.   

Abstract

The purpose of this paper is to describe the clinical characteristics and significance of the coronary arterial calcification due to Kawasaki disease (KD), based on our five patients. The coronary arterial lesions (CAL) were in segments 1, 2, 5, 6 and 11 according to the classification of the American Heart Association. The interval from the onset to the first appearance of coronary calcification was 17 months to 61 months. Progression of CAL into coronary arterial stenosis or myocardial infarction occurred in all five patients. In the comparative study between the patients with calcified CAL and those with non-calcified CAL, the maximal size of CAL of the former was 8 mm or larger in contrast with that of the latter (less than 8 mm). It is concluded that coronary arterial calcification is one of the important signs which suggest the presence of the advanced CAL in the follow-up of children with a history of KD.

Entities:  

Mesh:

Year:  1991        PMID: 1792902     DOI: 10.1111/j.1442-200x.1991.tb02569.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  3 in total

Review 1.  Kawasaki Disease update.

Authors:  Jane C Burns
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

2.  Usefulness of Calcium Scoring as a Screening Examination in Patients With a History of Kawasaki Disease.

Authors:  Andrew M Kahn; Matthew J Budoff; Lori B Daniels; Jun Oyamada; John B Gordon; Jane C Burns
Journal:  Am J Cardiol       Date:  2017-01-06       Impact factor: 2.778

3.  Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification.

Authors:  Chantale Lapierre; Audrey Bitsch; Ronald Guérin; Laurent Garel; Joaquim Miró; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2009-09-26       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.